Table 3.
Summary of second outcomes in this meta-analysis
| Outcome of interest | RPC + BRPC | RPC | BRPC | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Data sets | ES (95% CIs) | P value | I2 (%) | Data sets | ES (95% CIs) | P value | I2 (%) | Data sets | ES (95% CIs) | P value | I2 (%) | |
| DFS | 7 | 0.66 (0.53–0.83) | < 0.001 | 0 | 3 | 0.80 (0.59–1.07) | 0.137 | 0 | 2 | 0.44 (0.26–0.73) | 0.002 | 0 |
| Overall resection rate | 12 | 0.64 (0.37–1.10) | 0.104 | 60.0 | 6 | 0.50 (0.25–0.99) | 0.048 | 60.4 | 5 | 0.69 (0.41–1.16) | 0.159 | 36.1 |
| R0 rate | 19 | 2.83 (2.19–3.65) | < 0.001 | 40.2 | 8 | 1.95 (1.40–2.71) | < 0.001 | 22.3 | 6 | 4.75 (2.85–7.92) | < 0.001 | 16.4 |
| Recurrence | 12 | 0.65 (0.50–0.86) | 0.003 | 0 | 4 | 0.77 (0.55–1.08) | 0.131 | 0 | 5 | 0.41 (0.22–0.76) | 0.005 | 10.2 |
| pN+ rate | 18 | 0.30 (0.20–0.43) | < 0.001 | 58.4 | 7 | 0.28 (0.21–0.38) | < 0.001 | 0 | 6 | 0.23 (0.07–0.75) | 0.015 | 82.8 |
DFS disease-free survival, pN+ pathological positive lymph node, ES indicates effect size